APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Preparation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transdermal Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchTransdermal Preparation Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Preparation Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Transdermal Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Preparation Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Preparation Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Transdermal Preparation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Preparation include Novastage Pharmaceuticals (Shenzhen), Novartis, Luye Pharma Group, Hunan Jiudian Pharmaceutical, Harbin Hexinotai Pharmaceutical Technology, GSK, Demo Technology, Guangzhou Continent Biomedical Technology and Beijing Tide Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Preparation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Preparation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Preparation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Preparation market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Preparation Segment by Company

Novastage Pharmaceuticals (Shenzhen)

Novartis

Luye Pharma Group

Hunan Jiudian Pharmaceutical

Harbin Hexinotai Pharmaceutical Technology

GSK

Demo Technology

Guangzhou Continent Biomedical Technology

Beijing Tide Pharmaceutical

Viatris

Transdermal Corporation

Nitto

MEDRx

Medpharm

ERCO Pharma

4P Therapeutics

Transdermal Preparation Segment by Type

Injectable Preparations

Non Injectable Preparations

Transdermal Preparation Segment by Application

Hospital

Clinic

Other

Transdermal Preparation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Preparation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Preparation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transdermal Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transdermal Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transdermal Preparation Industry Trends Table 2. Transdermal Preparation Industry Drivers Table 3. Transdermal Preparation Industry Opportunities and Challenges Table 4. Transdermal Preparation Industry Restraints Table 5. Global Transdermal Preparation Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transdermal Preparation Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transdermal Preparation Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Transdermal Preparation Sales Market Share by Manufacturers Table 9. Global Transdermal Preparation Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Transdermal Preparation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transdermal Preparation Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transdermal Preparation Manufacturers, Product Type & Application Table 13. Global Transdermal Preparation Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Preparation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectable Preparations Table 17. Major Manufacturers of Non Injectable Preparations Table 18. Global Transdermal Preparation Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Transdermal Preparation Sales by Type (2021-2026) & (k units) Table 20. Global Transdermal Preparation Sales by Type (2027-2032) & (k units) Table 21. Global Transdermal Preparation Sales Market Share by Type (2021-2026) Table 22. Global Transdermal Preparation Sales Market Share by Type (2027-2032) Table 23. Global Transdermal Preparation Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Transdermal Preparation Revenue by Type (2021-2026) & (k units) Table 25. Global Transdermal Preparation Revenue by Type (2027-2032) & (k units) Table 26. Global Transdermal Preparation Revenue Market Share by Type (2021-2026) Table 27. Global Transdermal Preparation Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Transdermal Preparation Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Transdermal Preparation Sales by Application (2021-2026) & (k units) Table 33. Global Transdermal Preparation Sales by Application (2027-2032) & (k units) Table 34. Global Transdermal Preparation Sales Market Share by Application (2021-2026) Table 35. Global Transdermal Preparation Sales Market Share by Application (2027-2032) Table 36. Global Transdermal Preparation Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Transdermal Preparation Revenue by Application (2021-2026) & (k units) Table 38. Global Transdermal Preparation Revenue by Application (2027-2032) & (k units) Table 39. Global Transdermal Preparation Revenue Market Share by Application (2021-2026) Table 40. Global Transdermal Preparation Revenue Market Share by Application (2027-2032) Table 41. Global Transdermal Preparation Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Transdermal Preparation Sales by Region (2021-2026) & (k units) Table 43. Global Transdermal Preparation Sales Market Share by Region (2021-2026) Table 44. Global Transdermal Preparation Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Transdermal Preparation Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 48. North America Transdermal Preparation Sales by Country (2027-2032) & (k units) Table 49. Europe Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 51. Europe Transdermal Preparation Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Transdermal Preparation Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Transdermal Preparation Sales by Country (2027-2032) & (k units) Table 58. Global Transdermal Preparation Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Transdermal Preparation Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Transdermal Preparation Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Transdermal Preparation Revenue Market Share by Region (2021-2026) Table 62. Global Transdermal Preparation Revenue Market Share by Region (2027-2032) Table 63. Novastage Pharmaceuticals (Shenzhen) Company Information Table 64. Novastage Pharmaceuticals (Shenzhen) Business Overview Table 65. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio Table 67. Novastage Pharmaceuticals (Shenzhen) Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Transdermal Preparation Product Portfolio Table 72. Novartis Recent Development Table 73. Luye Pharma Group Company Information Table 74. Luye Pharma Group Business Overview Table 75. Luye Pharma Group Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Luye Pharma Group Transdermal Preparation Product Portfolio Table 77. Luye Pharma Group Recent Development Table 78. Hunan Jiudian Pharmaceutical Company Information Table 79. Hunan Jiudian Pharmaceutical Business Overview Table 80. Hunan Jiudian Pharmaceutical Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio Table 82. Hunan Jiudian Pharmaceutical Recent Development Table 83. Harbin Hexinotai Pharmaceutical Technology Company Information Table 84. Harbin Hexinotai Pharmaceutical Technology Business Overview Table 85. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio Table 87. Harbin Hexinotai Pharmaceutical Technology Recent Development Table 88. GSK Company Information Table 89. GSK Business Overview Table 90. GSK Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GSK Transdermal Preparation Product Portfolio Table 92. GSK Recent Development Table 93. Demo Technology Company Information Table 94. Demo Technology Business Overview Table 95. Demo Technology Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Demo Technology Transdermal Preparation Product Portfolio Table 97. Demo Technology Recent Development Table 98. Guangzhou Continent Biomedical Technology Company Information Table 99. Guangzhou Continent Biomedical Technology Business Overview Table 100. Guangzhou Continent Biomedical Technology Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio Table 102. Guangzhou Continent Biomedical Technology Recent Development Table 103. Beijing Tide Pharmaceutical Company Information Table 104. Beijing Tide Pharmaceutical Business Overview Table 105. Beijing Tide Pharmaceutical Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio Table 107. Beijing Tide Pharmaceutical Recent Development Table 108. Viatris Company Information Table 109. Viatris Business Overview Table 110. Viatris Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Viatris Transdermal Preparation Product Portfolio Table 112. Viatris Recent Development Table 113. Transdermal Corporation Company Information Table 114. Transdermal Corporation Business Overview Table 115. Transdermal Corporation Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Transdermal Corporation Transdermal Preparation Product Portfolio Table 117. Transdermal Corporation Recent Development Table 118. Nitto Company Information Table 119. Nitto Business Overview Table 120. Nitto Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Nitto Transdermal Preparation Product Portfolio Table 122. Nitto Recent Development Table 123. MEDRx Company Information Table 124. MEDRx Business Overview Table 125. MEDRx Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. MEDRx Transdermal Preparation Product Portfolio Table 127. MEDRx Recent Development Table 128. Medpharm Company Information Table 129. Medpharm Business Overview Table 130. Medpharm Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Medpharm Transdermal Preparation Product Portfolio Table 132. Medpharm Recent Development Table 133. ERCO Pharma Company Information Table 134. ERCO Pharma Business Overview Table 135. ERCO Pharma Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. ERCO Pharma Transdermal Preparation Product Portfolio Table 137. ERCO Pharma Recent Development Table 138. 4P Therapeutics Company Information Table 139. 4P Therapeutics Business Overview Table 140. 4P Therapeutics Transdermal Preparation Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. 4P Therapeutics Transdermal Preparation Product Portfolio Table 142. 4P Therapeutics Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Transdermal Preparation Distributors List Table 146. Transdermal Preparation Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Transdermal Preparation Product Image Figure 2. Global Transdermal Preparation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Preparation Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Preparation Sales (2021-2032) & (k units) Figure 5. Global Transdermal Preparation Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Transdermal Preparation Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectable Preparations Image Figure 9. Non Injectable Preparations Image Figure 10. Global Transdermal Preparation Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Transdermal Preparation Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Transdermal Preparation Sales Market Share by Type (2021-2032) Figure 13. Global Transdermal Preparation Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Transdermal Preparation Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Transdermal Preparation Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Transdermal Preparation Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Transdermal Preparation Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Transdermal Preparation Sales Market Share by Application (2021-2032) Figure 22. Global Transdermal Preparation Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Transdermal Preparation Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Transdermal Preparation Revenue Market Share by Application (2021-2032) Figure 25. North America Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Transdermal Preparation Sales Market Share by Country (2021-2032) Figure 27. U.S. Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Transdermal Preparation Sales Market Share by Country (2021-2032) Figure 32. Germany Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Transdermal Preparation Sales Market Share by Country (2021-2032) Figure 39. China Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Transdermal Preparation Sales Market Share by Country (2021-2032) Figure 47. Brazil Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Transdermal Preparation Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Transdermal Preparation Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Transdermal Preparation Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Transdermal Preparation Revenue (2021-2032) & (US$ Million) Figure 58. North America Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Transdermal Preparation Revenue (2021-2032) & (US$ Million) Figure 60. Europe Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Transdermal Preparation Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Transdermal Preparation Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Transdermal Preparation Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Transdermal Preparation Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Preparations
  • Non Injectable Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novastage Pharmaceuticals (Shenzhen)
  • Novartis
  • Luye Pharma Group
  • Hunan Jiudian Pharmaceutical
  • Harbin Hexinotai Pharmaceutical Technology
  • GSK
  • Demo Technology
  • Guangzhou Continent Biomedical Technology
  • Beijing Tide Pharmaceutical
  • Viatris
  • Transdermal Corporation
  • Nitto
  • MEDRx
  • Medpharm
  • ERCO Pharma
  • 4P Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transdermal Preparation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transdermal Preparation Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transdermal Preparation Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transdermal Preparation Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transdermal Preparation Market Dynamics
  1. 2.1 Transdermal Preparation Industry Trends
  2. 2.2 Transdermal Preparation Industry Drivers
  3. 2.3 Transdermal Preparation Industry Opportunities and Challenges
  4. 2.4 Transdermal Preparation Industry Restraints
3 Transdermal Preparation Market by Manufacturers
  1. 3.1 Global Transdermal Preparation Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transdermal Preparation Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Preparation Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Preparation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Preparation Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transdermal Preparation Manufacturers, Product Type & Application
  7. 3.7 Global Transdermal Preparation Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Preparation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Preparation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Preparation Tier 1, Tier 2, and Tier 3
4 Transdermal Preparation Market by Type
  1. 4.1 Transdermal Preparation Type Introduction
  2. 4.1.1 Injectable Preparations
  3. 4.1.2 Non Injectable Preparations
  4. 4.2 Global Transdermal Preparation Sales by Type
  5. 4.2.1 Global Transdermal Preparation Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Transdermal Preparation Sales by Type (2021-2032)
  7. 4.2.3 Global Transdermal Preparation Sales Market Share by Type (2021-2032)
  8. 4.3 Global Transdermal Preparation Revenue by Type
  9. 4.3.1 Global Transdermal Preparation Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Transdermal Preparation Revenue by Type (2021-2032)
  11. 4.3.3 Global Transdermal Preparation Revenue Market Share by Type (2021-2032)
5 Transdermal Preparation Market by Application
  1. 5.1 Transdermal Preparation Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Transdermal Preparation Sales by Application
  6. 5.2.1 Global Transdermal Preparation Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transdermal Preparation Sales by Application (2021-2032)
  8. 5.2.3 Global Transdermal Preparation Sales Market Share by Application (2021-2032)
  9. 5.3 Global Transdermal Preparation Revenue by Application
  10. 5.3.1 Global Transdermal Preparation Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transdermal Preparation Revenue by Application (2021-2032)
  12. 5.3.3 Global Transdermal Preparation Revenue Market Share by Application (2021-2032)
6 Global Transdermal Preparation Sales by Region
  1. 6.1 Global Transdermal Preparation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Preparation Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Preparation Sales by Region (2021-2026)
  4. 6.2.2 Global Transdermal Preparation Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transdermal Preparation Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transdermal Preparation Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transdermal Preparation Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transdermal Preparation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transdermal Preparation Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transdermal Preparation Revenue by Region
  1. 7.1 Global Transdermal Preparation Revenue by Region
  2. 7.1.1 Global Transdermal Preparation Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transdermal Preparation Revenue by Region (2021-2026)
  4. 7.1.3 Global Transdermal Preparation Revenue by Region (2027-2032)
  5. 7.1.4 Global Transdermal Preparation Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transdermal Preparation Revenue (2021-2032)
  8. 7.2.2 North America Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transdermal Preparation Revenue (2021-2032)
  11. 7.3.2 Europe Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transdermal Preparation Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transdermal Preparation Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transdermal Preparation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novastage Pharmaceuticals (Shenzhen)
  2. 8.1.1 Novastage Pharmaceuticals (Shenzhen) Company Information
  3. 8.1.2 Novastage Pharmaceuticals (Shenzhen) Business Overview
  4. 8.1.3 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio
  6. 8.1.5 Novastage Pharmaceuticals (Shenzhen) Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Transdermal Preparation Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Luye Pharma Group
  14. 8.3.1 Luye Pharma Group Company Information
  15. 8.3.2 Luye Pharma Group Business Overview
  16. 8.3.3 Luye Pharma Group Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Luye Pharma Group Transdermal Preparation Product Portfolio
  18. 8.3.5 Luye Pharma Group Recent Developments
  19. 8.4 Hunan Jiudian Pharmaceutical
  20. 8.4.1 Hunan Jiudian Pharmaceutical Company Information
  21. 8.4.2 Hunan Jiudian Pharmaceutical Business Overview
  22. 8.4.3 Hunan Jiudian Pharmaceutical Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio
  24. 8.4.5 Hunan Jiudian Pharmaceutical Recent Developments
  25. 8.5 Harbin Hexinotai Pharmaceutical Technology
  26. 8.5.1 Harbin Hexinotai Pharmaceutical Technology Company Information
  27. 8.5.2 Harbin Hexinotai Pharmaceutical Technology Business Overview
  28. 8.5.3 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio
  30. 8.5.5 Harbin Hexinotai Pharmaceutical Technology Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Transdermal Preparation Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Demo Technology
  38. 8.7.1 Demo Technology Company Information
  39. 8.7.2 Demo Technology Business Overview
  40. 8.7.3 Demo Technology Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Demo Technology Transdermal Preparation Product Portfolio
  42. 8.7.5 Demo Technology Recent Developments
  43. 8.8 Guangzhou Continent Biomedical Technology
  44. 8.8.1 Guangzhou Continent Biomedical Technology Company Information
  45. 8.8.2 Guangzhou Continent Biomedical Technology Business Overview
  46. 8.8.3 Guangzhou Continent Biomedical Technology Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio
  48. 8.8.5 Guangzhou Continent Biomedical Technology Recent Developments
  49. 8.9 Beijing Tide Pharmaceutical
  50. 8.9.1 Beijing Tide Pharmaceutical Company Information
  51. 8.9.2 Beijing Tide Pharmaceutical Business Overview
  52. 8.9.3 Beijing Tide Pharmaceutical Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio
  54. 8.9.5 Beijing Tide Pharmaceutical Recent Developments
  55. 8.10 Viatris
  56. 8.10.1 Viatris Company Information
  57. 8.10.2 Viatris Business Overview
  58. 8.10.3 Viatris Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Viatris Transdermal Preparation Product Portfolio
  60. 8.10.5 Viatris Recent Developments
  61. 8.11 Transdermal Corporation
  62. 8.11.1 Transdermal Corporation Company Information
  63. 8.11.2 Transdermal Corporation Business Overview
  64. 8.11.3 Transdermal Corporation Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Transdermal Corporation Transdermal Preparation Product Portfolio
  66. 8.11.5 Transdermal Corporation Recent Developments
  67. 8.12 Nitto
  68. 8.12.1 Nitto Company Information
  69. 8.12.2 Nitto Business Overview
  70. 8.12.3 Nitto Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nitto Transdermal Preparation Product Portfolio
  72. 8.12.5 Nitto Recent Developments
  73. 8.13 MEDRx
  74. 8.13.1 MEDRx Company Information
  75. 8.13.2 MEDRx Business Overview
  76. 8.13.3 MEDRx Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MEDRx Transdermal Preparation Product Portfolio
  78. 8.13.5 MEDRx Recent Developments
  79. 8.14 Medpharm
  80. 8.14.1 Medpharm Company Information
  81. 8.14.2 Medpharm Business Overview
  82. 8.14.3 Medpharm Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Medpharm Transdermal Preparation Product Portfolio
  84. 8.14.5 Medpharm Recent Developments
  85. 8.15 ERCO Pharma
  86. 8.15.1 ERCO Pharma Company Information
  87. 8.15.2 ERCO Pharma Business Overview
  88. 8.15.3 ERCO Pharma Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ERCO Pharma Transdermal Preparation Product Portfolio
  90. 8.15.5 ERCO Pharma Recent Developments
  91. 8.16 4P Therapeutics
  92. 8.16.1 4P Therapeutics Company Information
  93. 8.16.2 4P Therapeutics Business Overview
  94. 8.16.3 4P Therapeutics Transdermal Preparation Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 4P Therapeutics Transdermal Preparation Product Portfolio
  96. 8.16.5 4P Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Preparation Value Chain Analysis
  2. 9.1.1 Transdermal Preparation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Preparation Production Mode & Process
  6. 9.2 Transdermal Preparation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Preparation Distributors
  9. 9.2.3 Transdermal Preparation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst